Table 2.
Clinical and biochemical pre‐eclampsia‐related findings in pregnant women with COVID‐19 before, during and after severe pneumonia
Variables | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | |
---|---|---|---|---|---|---|---|---|---|
Before severe pneumonia | GA (weeks) | 30+0 | 22+6 | 37+5 | 36+4 | 32+0 | 20+3 | 27+4 | 20+1 |
SBP (mmHg) | 130 | 120 | 123 | 117 | 104 | 135 | 107 | 116 | |
DBP (mmHg) | 74 | 72 | 74 | 67 | 71 | 76 | 67 | 63 | |
MAP (mmHg) | 92.7 | 88.0 | 90.3 | 83.7 | 82.0 | 95.7 | 80.3 | 80.7 | |
Prot/creat (mg/g) | 37 | 180 | — | — | — | — | — | — | |
AST (U/l) | 17 | 19 | 15 | 20 | 26 | 19 | 23 | 14 | |
ALT (U/l) | 16 | 30 | 13 | 26 | 20 | 12 | 14 | 22 | |
Platelets/µl | 158 000 | 242 000 | 402 000 | 210 000 | 275 000 | 234 000 | 319 000 | 242 000 | |
LDH (U/l) | — | — | — | — | — | — | — | — | |
D‐dimer (mg/ml) | — | — | — | — | — | — | — | — | |
Creatinine (mg/dl) | 0.63 | 0.49 | — | 0.79 | 0.74 | 0.36 | 0.45 | 0.66 | |
UtAPI >95th centile | No | No | Yes | No | No | No | No | No | |
PE/HELLP diagnostic criteria | No | No | No | No | No | No | No | No | |
During severe pneumonia | GA (weeks) | 30+1 | 24+4 | 37+6 | 36+5 | 32+1 | 20+4 | 28+3 | 20+2 |
SBP (mmHg) | 145 | 168 | 156 | 155 | 116 | 115 | 140 | 108 | |
DBP (mmHg) | 90 | 116 | 98 | 108 | 70 | 68 | 105 | 69 | |
MAP (mmHg) | 108.3 | 133.3 | 117.3 | 123.7 | 85.3 | 83.7 | 116.7 | 82.0 | |
Prot/creat (mg/g) | 855 | 622 | 378 | 514 | 396 | 49 | 948 | 130 | |
AST (U/l) | 153 | 122 | 104 | 62 | 38 | 52 | 138 | 113 | |
ALT (U/l) | 170 | 136 | 52 | 39 | 38 | 14 | 65 | 230 | |
Platelets/µl | 324 000 | 160 000 | 279 000 | 231 000 | 336 000 | 243 000 | 108 000 | 505 000 | |
LDH (U/l) | 482 | 370 | 672 | 555 | 517 | 176 | 463 | 312 | |
D‐dimer (mg/ml) | 457 | 2129 | 5065 | 1800 | 326 | 119 | 514 | 376 | |
Creatinine (mg/dl) | 0.34 | 0.42 | 0.85 | 0.88 | 0.42 | 0.20 | 0.39 | 0.26 | |
Hidralazine | Yes | Yes | Yes | Yes | No | No | No | No | |
Labetalol | Yes | Yes | Yes | Yes | No | No | Yes | No | |
sFlt‐1/PlGF | 9.40 | 20.24 | 378.90 | 49.36 | 24.78 | 4.60 | 7.60 | 5.19 | |
UtAPI >95th centile | No | No | Yes | No | No | No | No | No | |
PE/HELLP diagnostic criteria | Yes | Yes | Yes | Yes | No | No | Yes | No | |
After severe pneumonia | GA at delivery (weeks) | 30+1 | Not delivered | 37+6 | 36+6 | Not delivered | Not delivered | 28+3 | Not delivered |
Reason for delivery | HELLP | — | SARS | SARS | — | — | SARS | — | |
GA (weeks) | — | 25.5 | — | — | 33.2 | 21.5 | — | 21.3 | |
SBP (mmHg) | 123 | 132 | 142 | 115 | 116 | 108 | 109 | 110 | |
DBP (mmHg) | 83 | 75 | 93 | 68 | 79 | 62 | 75 | 64 | |
MAP (mmHg) | 96.3 | 94.0 | 109.3 | 83.7 | 91.3 | 77.3 | 86.3 | 79.3 | |
Prot/creat (mg/g) | 210 | 183 | 426 | 83 | 115 | 83 | 189 | 128 | |
AST (U/l) | 39 | 32 | 56 | 43 | 58 | — | 23 | 61 | |
ALT (U/l) | 45 | 132 | 41 | 29 | 55 | — | 29 | 172 | |
Platelets/µl | 312 000 | 218 000 | 232 000 | 258 000 | 292 000 | 169 000 | 364 000 | 762 000 | |
LDH (U/l) | 222 | 277 | 692 | 325 | 211 | — | 353 | 192 | |
D‐dimer (mg/ml) | 617 | 1745 | 3258 | — | 454 | — | 347 | 470 | |
Creatinine (mg/dl) | 0.25 | 0.3 | 0.58 | — | 0.41 | — | 0.42 | 0.65 | |
UtAPI >95th centile | — | No | — | — | No | No | — | No | |
PE/HELLP diagnostic criteria | No | No | Yes | No | No | No | No | No |
ALT, alanine amninotransferase; AST, aspartate aminotransferase; DBP, diastolic blood pressure; GA, gestational age; LDH, lactate dehydrogenase; MAP, mean arterial pressure; PE, pre‐eclampsia; PlGF, placental growth factor; prot/creat; urine protein to creatinine ratio; SARS, severe acute respiratory syndrome; sFlt‐1, soluble fms‐like tyrosine kinase‐1; UtAPI, uterine artery pulsatility index.